Smith Kenneth, Garman Lori, Wrammert Jens, Zheng Nai-Ying, Capra J Donald, Ahmed Rafi, Wilson Patrick C
Department of Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, OK 73104, USA.
Nat Protoc. 2009;4(3):372-84. doi: 10.1038/nprot.2009.3.
We describe herein a protocol for the production of antigen-specific human monoclonal antibodies (hmAbs). Antibody-secreting cells (ASCs) are isolated from whole blood collected 7 d after vaccination and sorted by flow cytometry into single cell plates. The antibody genes of the ASCs are then amplified by RT-PCR and nested PCR, cloned into expression vectors and transfected into a human cell line. The expressed antibodies can then be purified and assayed for binding and neutralization. This method uses established techniques but is novel in their combination and application. This protocol can be completed with as little as 20 ml of human blood and in as little as 28 d when optimal. Although previous methodologies to produce hmAbs, including B-cell immortalization or phage display, can be used to isolate the rare specific antibody even years after immunization, in comparison, these approaches are inefficient, resulting in few relevant antibodies. Although dependent on having an ongoing immune response, the approach described herein can be used to rapidly generate numerous antigen-specific hmAbs in a short time.
我们在此描述一种生产抗原特异性人单克隆抗体(hmAbs)的方案。抗体分泌细胞(ASCs)从接种疫苗7天后采集的全血中分离出来,并通过流式细胞术分选到单细胞培养板中。然后通过逆转录聚合酶链反应(RT-PCR)和巢式PCR扩增ASCs的抗体基因,克隆到表达载体中并转染到人细胞系中。随后可以纯化表达的抗体并检测其结合和中和能力。该方法使用的是成熟技术,但在其组合和应用方面具有新颖性。该方案最少只需20毫升人血,在最佳情况下最短28天即可完成。尽管以前生产hmAbs的方法,包括B细胞永生化或噬菌体展示,即使在免疫数年之后也可用于分离罕见的特异性抗体,但相比之下,这些方法效率低下,产生的相关抗体很少。尽管依赖于持续的免疫反应,但本文所述方法可用于在短时间内快速产生大量抗原特异性hmAbs。